Mathematical models show one dose of Shanchol may be sufficient during epidemics

Shanchol, the cholera vaccine used in endemic countries, is given in two doses 6 weeks apart. But some patients may simply not return for a second dose. If the second dose is delayed by more than 6 weeks, the WHO says, the whole regimen has to be restarted. According to a researcher at the Johns Hopkins Bloomberg School of Public Health, a single dose of Shanchol may provide sufficient protection in an epidemic. Andrew Azman used mathematical models to determine "minimum relative single-dose efficacy," the point at which a single-dose cholera vaccine campaign could be equally or more effective than a two-dose campaign in hypothetical epidemics. His models were based on outbreaks in Guinea, Zimbabwe and Haiti. And while Azman and his colleagues found evidence that a single dose of Shantha's Shanchol might be sufficient, "substantial uncertainty about one-dose efficacy remains" and field studies in areas with periodic cholera outbreaks are a priority, the team wrote. More

Suggested Articles

As of Friday after local time, 36 people have died in Korea after getting flu shots provided by at least seven companies, including Sanofi.

As COVID-19 vaccines advance, the FDA held an expert hearing Thursday to talk safety, efficacy, distribution plans and vaccine confidence—plus more. 

Moderna, racing ahead with COVID-19 vaccine R&D, completed enrollment for its late-stage trial—and moved one step closer to approval.